Insider Transactions in Q2 2021 at Organogenesis Holdings Inc. (ORGO)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 09
2021
|
Albert Erani Family Trust Dated 12/29/2012 > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
150,000
-0.25%
|
$2,250,000
$15.31 P/Share
|
|
Jun 09
2021
|
Albert Erani > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
150,000
-0.25%
|
$2,250,000
$15.31 P/Share
|
|
Jun 08
2021
|
Albert Erani Family Trust Dated 12/29/2012 > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100,000
-0.17%
|
$1,500,000
$15.41 P/Share
|
|
Jun 08
2021
|
Albert Erani > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100,000
-0.17%
|
$1,500,000
$15.41 P/Share
|
|
Jun 07
2021
|
Albert Erani Family Trust Dated 12/29/2012 > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
94,612
-0.16%
|
$1,513,792
$16.14 P/Share
|
|
Jun 07
2021
|
Albert Erani > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
94,612
-0.16%
|
$1,513,792
$16.14 P/Share
|
|
Jun 04
2021
|
Albert Erani Family Trust Dated 12/29/2012 > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
60,000
-0.1%
|
$960,000
$16.22 P/Share
|
|
Jun 04
2021
|
Albert Erani > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
60,000
-0.1%
|
$960,000
$16.22 P/Share
|
|
May 27
2021
|
Dennis Erani > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
9,106
-0.69%
|
$163,908
$18.97 P/Share
|
|
May 27
2021
|
Alan A. Ades Director |
SELL
Open market or private sale
|
Direct |
3,887,500
-6.1%
|
$62,200,000
$16.4 P/Share
|
|
May 27
2021
|
Glenn H Nussdorf Director |
SELL
Open market or private sale
|
Direct |
3,887,500
-6.1%
|
$62,200,000
$16.4 P/Share
|
|
May 14
2021
|
Avista Capital Managing Member Iv, LLC |
SELL
Other acquisition or disposition
|
Indirect |
21,154,526
-73.26%
|
-
|
|
May 07
2021
|
Jon L Giacomin Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,319
+50.0%
|
-
|
|
May 06
2021
|
Alan A. Ades Director |
BUY
Other acquisition or disposition
|
Direct |
19,550,714
+6.09%
|
-
|
|
May 06
2021
|
Alan A. Ades Director |
SELL
Other acquisition or disposition
|
Direct |
23,855,148
-35.07%
|
-
|
|
May 06
2021
|
Glenn H Nussdorf Director |
BUY
Other acquisition or disposition
|
Direct |
19,550,714
+6.09%
|
-
|
|
May 06
2021
|
Glenn H Nussdorf Director |
SELL
Other acquisition or disposition
|
Direct |
23,855,148
-35.07%
|
-
|
|
Apr 09
2021
|
Starr Wisdom > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,000
-50.0%
|
$440,000
$22.11 P/Share
|
|
Apr 01
2021
|
Antonio S. Montecalvo Vice President, Health Policy |
SELL
Payment of exercise price or tax liability
|
Direct |
1,770
-2.48%
|
$33,630
$19.83 P/Share
|
|
Apr 01
2021
|
Gary S. Gillheeney President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,265
-4.48%
|
$119,035
$19.83 P/Share
|
|
Apr 01
2021
|
Lori Freedman Chief Admin. and Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,975
-5.53%
|
$37,525
$19.83 P/Share
|
|
Apr 01
2021
|
Patrick Bilbo Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,497
-1.5%
|
$47,443
$19.83 P/Share
|
|
Apr 01
2021
|
Brian Grow Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,977
-4.25%
|
$37,563
$19.83 P/Share
|